Lex Aurum Advisors, LLC Amgen Inc Transaction History

Lex Aurum Advisors, LLC

$476 Million
Q4 2024

A detailed history of Lex Aurum Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Lex Aurum Advisors, LLC holds 1,458 shares of AMGN stock, worth $401,562. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,458

Previous 1,194 22.11%

Holding current value

$401,562

Previous $384,000 1.04%

% of portfolio

0.08%

Previous 0.09%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	BUY	$258.78 - $328.31 $68,317 - $86,673	264 Added 22.11%	1,458 $380,000
Q3 2024 Oct 16, 2024	SELL	$309.38 - $337.38 $5,878 - $6,410	-19 Reduced 1.57%	1,194 $384,000
Q2 2024 Jul 15, 2024	BUY	$262.75 - $319.31 $262 - $319	1 Added 0.08%	1,213 $379,000
Q1 2024 Apr 10, 2024	BUY	$268.87 - $324.56 $62,377 - $75,297	232 Added 23.67%	1,212 $344,000
Q4 2023 Jan 10, 2024	BUY	$255.7 - $288.46 $255 - $288	1 Added 0.1%	980 $282,000
Q3 2023 Oct 16, 2023	BUY	$218.65 - $271.46 $214,058 - $265,759	979 New	979 $263,000
Q1 2023 Apr 11, 2023	BUY	$225.79 - $275.2 $1,128 - $1,376	5 Added 0.51%	981 $237,000
Q4 2022 Jan 23, 2023	SELL	$229.03 - $291.01 $5,725 - $7,275	-25 Reduced 2.5%	976 $0
Q3 2022 Oct 17, 2022	BUY	$224.46 - $253.15 $3,142 - $3,544	14 Added 1.42%	1,001 $226,000
Q1 2022 May 04, 2022	SELL	$219.27 - $242.57 $208,525 - $230,684	-951 Reduced 49.07%	987 $239,000
Q4 2021 Jan 24, 2022	BUY	$198.88 - $227.6 $198 - $227	1 Added 0.05%	1,938 $436,000
Q3 2021 Nov 03, 2021	SELL	$212.27 - $248.7 $33,963 - $39,792	-160 Reduced 7.63%	1,937 $412,000
Q2 2021 Jul 19, 2021	SELL	$233.58 - $259.14 $6,540 - $7,255	-28 Reduced 1.32%	2,097 $511,000
Q1 2021 Apr 22, 2021	BUY	$221.91 - $258.6 $13,092 - $15,257	59 Added 2.86%	2,125 $529,000
Q4 2020 Jan 20, 2021	SELL	$216.38 - $257.67 $10,169 - $12,110	-47 Reduced 2.22%	2,066 $475,000
Q3 2020 Oct 22, 2020	BUY	$234.65 - $260.95 $469 - $521	2 Added 0.09%	2,113 $537,000
Q2 2020 Jul 22, 2020	BUY	$197.81 - $242.74 $593 - $728	3 Added 0.14%	2,111 $498,000
Q1 2020 Apr 22, 2020	BUY	$182.24 - $241.7 $189,165 - $250,884	1,038 Added 97.01%	2,108 $427,000
Q4 2019 Jan 27, 2020	BUY	$189.21 - $243.2 $202,454 - $260,224	1,070 New	1,070 $258,000

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

404M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $147B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lex Aurum Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lex Aurum Advisors, LLC with notifications on news.

Account

Lex Aurum Advisors, LLC Amgen Inc Transaction History